May 20th 2024
Recent sessions cast spotlight on emerging technologies and therapies.
(COPE Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(CME Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
2nd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
May 18-19, 2024
Register Now!
(COPE Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
(COPE Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
(CME Credit) Virtual Case Studies™ in Cataract Surgery: Selecting Surgical Techniques and Preventing Intra-Operative Complications
View More
Neurotrophic Keratitis Management: How Early Intervention Can Make a Difference
View More
(CME Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
17th Annual Controversies in Modern Eye Care
View More
Thyroid Eye Disease: The Masquerading Eye Disorder—A Guide to Collaborative Care and Accurate Diagnosis
View More
(COPE Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(CME Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(CME Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(COPE Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
The Ins and Outs of Lubricating Eye Drops
View More
What’s New in MGD Beyond Heating and Squeezing?
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Expert Perspectives in Diabetic Macular Edema – Considering Pathogenesis & Inflammation in Treatment Selection
View More
Community Practice Connections™: Novel Treatment Strategies in the Management of nAMD & DME - Lessons from Clinical Trial and Real-World Data
View More
Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (CME Credit)
View More
Medical Crossfire®: Expert Insights in Anti-VEGF Dosing for nAMD and DME – Optimizing Reduction in Treatment Burden
View More
Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (COPE Credit)
View More
EyeCon 2024
September 27-28, 2024
Register Now!
Heading to AAO? You’re invited to a CME dinner. Or join virtually!
Date TBA
Register Now!
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (CME/CNE Credit)
View More
(COPE) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)
View More
Another approach for presbyopia on the horizon
October 23rd 2004NuLens Ltd., a company formed 2 years ago in Herzliya Pituach, Israel, has developed a new accommodative IOL technology that offers more than 10 D of accommodative power, according to Joshua Ben-Nun, MD, chief scientific officer, NuLens, who spoke at a breakfast session during the American Academy of Ophthalmology annual meeting.
Read More
Late onset bleb leakage should be managed carefully
October 23rd 2004Late onset bleb leakage usually occurs 2 to 3 years after glaucoma filtering surgery with an incidence between 2% and 9%. This condition warrants treatment, according to Philip P. Chen, MD, who spoke during the glaucoma subspecialty day meeting.
Read More
12-month results positive for laser presbyopia reversal
October 22nd 2004Laser presbyopia reversal (LAPR) is showing significant promise and patient satisfaction based on 12-month follow-up results from a U.S. clinical trial, said Sandra C. Belmont, MD, at the refractive surgery subspecialty day meeting.
Read More
12-month results positive for laser presbyopia reversal
October 22nd 2004Laser presbyopia reversal (LAPR) is showing significant promise and patient satisfaction based on 12-month follow-up results from a U.S. clinical trial, said Sandra C. Belmont, MD, at the refractive surgery subspecialty day meeting.
Read More
Botulinum toxin improves blepharospasm symptoms
October 15th 2004S?o Paulo, Brazil-Botulinum toxin type A (Botox, Allergan) significantly improves all aspects of quality of life in patients with blepharospasm, according to Tammy Osaki, MS, a medical student at the Vision Institute of the Federal University of S?o Paulo, Brazil.
Read More
No need to dissect conjunctiva during posterior vitrectomy
October 15th 2004San Diego-A system for performing a sutureless posterior vitrectomy uses 25-gauge cannula instruments that can be inserted directly through the conjunctiva and eliminates the need for its dissection. The transconjunctival sutureless vitrectomy system (TSV25, Bausch & Lomb) reduces the problems associated with performing surgery in eyes with a shallow anterior chamber, according to Rosa Braga-Mele, MD.
Read More
Radial scleral ablation trial promising for presbyopia
October 1st 2004San Diego-Scleral ablation with the 2.94 erbium:YAG laser for the treatment of presbyopia seems to be an effective and safe procedure in most patients, according to Bobby Maddox, MD, here at the American Society of Cataract and Refractive Surgery annual meeting.
Read More
Implant shows success in treating posterior uveitis
October 1st 2004Durham, NC-Results of a 9-month randomized, dose-masked, multicenter clinical trial of a fluocinolone acetonide sustained drug delivery system to treat posterior uveitis resulted in significant gains for the eyes that received implants when compared with fellow eyes that did not receive implants, said Glenn J. Jaffe, MD.
Read More
New Orleans hosts first joint meeting of AAO, SOE
October 1st 2004That particular charm that belongs only to New Orleans has lured the American Academy of Ophthalmology (AAO) back to this magical city for its annual meeting.The 2004 meeting is the first joint meeting with the European Society of Ophthalmology (SOE).The main meeting will be preceded by 2 days of subspecialty presentations on Friday, Oct. 22 and Saturday, Oct. 23. All subspecialty day events and those of the main conference, Oct. 23 to 26, will be held at the Ernest N. Morial Convention Center.
Read More
NuLens presents a new concept for an accommodating IOL
September 18th 2004With some of the leading ophthalmic surgeons and researchers from Europe and the United States in attendance, NuLens Ltd. introduced a new concept of accommodative IOLs for the treatment of presbyopia during an off-site presentation at the European Society of Cataract and Refractive Surgeons meeting.
Read More
Ultrathin lens with high power ideal for microphthalmos
September 15th 2004San Diego-A new ultrathin IOL available in extremely high refractive powers offers distinct advantages over traditional thicker lenses or piggyback lenses for correction of hyperopia in patients with microphthalmos, according to Jochen Kammann, MD.
Read More
RLE for high myopia considered safe, effective in short term
September 15th 2004San Diego-With the availability of foldable IOLs able to correct up to -31 D of spherical error, refractive lens exchange (RLE) for high myopia is now an option for patients hoping to achieve a good refractive outcome. However, patients will need to be monitored long term for potential complications, such as retinal detachments and posterior capsular opacification (PCO), explained Thomas Kohnen, MD, who spoke during the American Society of Cataract and Refractive Surgery annual meeting.
Read More
Comprehensive updates on retina, refractive, and glaucoma await ophthalmic delegates
September 1st 2004Don't miss "Ultimate Grand Rounds: Challenges in Cataract Surgery and Corneal Disease" (Sunday, Oct. 24, 10:40 a.m. to 12:10 p.m.), which is an exciting new session on cataract surgery and corneal disease. It will feature debates on case studies covering topics such as capsular tension rings, vitreous loss, multifocal IOLs, pterygium, herpes, dry eye, management of Fuchs' dystrophy, and cataract.
Read More
Survey highlights trends in managing anophthalmic socket
September 1st 2004Houston-A number of surgical options are available for managing the anophthalmic socket after primary enucleation and evisceration. However, there is little consensus about what implant or wrapping material is preferred, according to Grant W. Su, MD.
Read More
Phakic IOL could contribute to faulty IOL power calculations
September 1st 2004San Diego-Phakic anterior chamber IOLs affect the biometric measurement of axial length, which results in clinically significant errors in IOL power calculations in patients who need to undergo cataract surgery. Gerald Zaidman, MD, described such a patient and offered suggestions for managing this complicated problem here at the American Society of Cataract and Refractive Surgery.
Read More
CO2 Laser a useful tool for nonpenetrating deep sclerectomy
August 1st 2004Fort Lauderdale, FL-Initial clinical trial experience suggests that CO2 laser-assisted nonpenetrating deep scle- rectomy (NPDS) holds promise as an excellent option for glaucoma therapy, said Ehud I. Assia, MD, at the annual meeting of the Association for Research in Vision and Ophthalmology.
Read More
Relative toxicity of four ophthalmic antibiotics studied
August 1st 2004Fort Lauderdale, FL-In a comparison study that has implications for wound healing in surface ablation procedures, investigators found that four commonly used topical ophthalmic antibiotics-moxifloxacin (Vigamox, Alcon), levofloxacin (Quixin, Santen), gatifloxacin (Zymar, Allergan), and ofloxacin (Ocuflox, Allergan)-all showed evidence of toxicity on human corneal epithelial cells, with moxifloxacin causing the least amount of toxicity.
Read More
Outcomes favorable in 2-year experience with silicone IOL
July 15th 2004San Diego - Two-year follow-up of eyes with the ClariFlex with OptiEdge silicone IOL (AMO) implanted show that the second-generation silicone IOL with its novel edge design is performing well. Furthermore, risk of posterior capsular opacification (PCO) and glare was minimal, according to the results of a study presented by Elizabeth A. Davis, MD, FACS, at the annual meeting of the American Society of Cataract and Refractive Surgery.
Read More